# MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/met-tyrosine-kinase-inhibitor-crizotinib-pf-02341066-shows-differential/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Junko Tanizaki,Isamu Okamoto,Kunio Okamoto,Ken Takezawa,Kiyoko Kuwata,Haruka Yamaguchi,Kazuhiko Nakagawa |
| Citations | 126 |
| DOI | 10.1097/jto.0b013e31822591e9 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086415331981/pdf |
| OpenAlex ID | https://openalex.org/W2014275502 |
| PMID | 21716144 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Kunio Okamoto](https://scholariq.org/researchers/kunio-okamoto/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Liver physiology and pathology](https://scholariq.org/topics/liver-physiology-and-pathology/)
- [Cell death mechanisms and regulation](https://scholariq.org/topics/cell-death-mechanisms-and-regulation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.